Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus.
J Virol Methods
Max Planck Institute for Dynamics of Complex Technical Systems, Sandtorstreet 1, D-39106 Magdeburg, Germany.
Published: December 2004
Three assay methods were investigated for monitoring the time-course of neuraminidase (NA) activity of tissue culture derived equine influenza A virus from large-scale microcarrier cultivation and several steps of downstream processing required for the production of inactivated vaccines. Measurements of neuraminidase activity by a thiobarbituric acid (TBA) and a fluorometric method using Amplex Red as a fluorogen (FL-AR) did not correlate with the increase of hemagglutinin (HA) during virus replication. Samples analysed by the TBA method showed unspecific interference from low molecular weight compounds (< 3 kDa) of cell growth medium and virus maintenance medium. Further investigations showed that this was probably caused by interfering reactions between reducing sugars and amino acids that can be overcome by dialysis of samples. On the other hand, the sensitivity of the FL-AR method was not sufficient for the required measuring range. However, a reliable and sensitive fluorometric assay method (FL-MU-NANA) was obtained using 4-methylumbelliferyl-alpha-d-N-acetylneuraminic acid (4-MU-NANA) as a substrate, which allowed the detection of neuraminidase activities as low as 0.09 mU/mL. In this assay, time-course of neuraminidase activities correlated well with increasing hemagglutinin activities during virus replication in a bioreactor. Analysis of samples from various downstream processing steps comprising of clarification, inactivation, ultrafiltration (UF) and size-exclusion chromatography for the purification of influenza virus showed that neuraminidase activity was preserved at comparatively high levels. Based on the hemagglutinin and neuraminidase activity of the clarified and inactivated virus harvest, the overall recovery after gel filtration was about 34.4% and 119.5%, respectively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jviromet.2004.07.005 | DOI Listing |
Similar Publications
Novel derivatives of thiohydantoin-containing tetrahydro-β-carboline possess activity against influenza virus at late stages of viral cycle without affecting viral neuraminidase.
Arch Pharm (Weinheim)
March 2025
Department of Virology, St. Petersburg Pasteur Institute, St. Petersburg, Russia.
Influenza infection represents a serious challenge for virological surveillance and healthcare systems in all countries globally. Despite obvious success in control of influenza through vaccination and antiviral drug development, this infection remains poorly controlled due to antigenic drift and fast selection of drug-resistant viral variants. The design of novel drugs with alternative targets and mechanisms of action is, therefore, an important goal for medical science worldwide.
View Article and Find Full Text PDFDuring 2023-2024, highly pathogenic avian influenza A(H5N1) viruses from clade 2.3.2.
View Article and Find Full Text PDFA novel multi-epitope-based peptide recombinant influenza A vaccine prototype utilizing neuraminidase and hemagglutinin surface proteins: From in silico to preliminary study.
Comput Biol Chem
February 2025
Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Neuraminidase and hemagglutinin serve as the crucial surface proteins of influenza viruses. Hemagglutinin, as a variable surface protein, is indispensable for vaccine development. Therefore, Neuraminidase must not be overlooked in the formulation of the recombinant vaccine prototype, which may serve as a candidate for designing a multi-epitope recombinant vaccine using immunoinformatics.
View Article and Find Full Text PDFNative Capillary Nanogel Electrophoresis Assay of Inhibitors of Neuraminidases Derived from H1N1 and H5N1 Influenza A Pandemics.
Anal Chem
March 2025
C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia 26505, United States.
Tetrameric neuraminidases cleave the end-capping sialylated monomer from oligosaccharide ligands at the surface of a host cell infected by the influenza A virus. This cleavage releases the replicated virions from the host cell, making drugs that inhibit neuraminidase function effective to treat influenza A infections. A capillary electrophoresis separation-based assay is reported that maintains the native structure of tetrameric viral neuraminidases derived from H1N1 or H5N1 influenza A pandemics which convert, in-real time, a substrate that mimics 6'-sialyllated threonine-linked glycans on human cells.
View Article and Find Full Text PDFPhylogenomic Analyses of the Hemagglutinin-Neuraminidase () Gene in Human Parainfluenza Virus Type 4 Isolates in Japan.
Microorganisms
February 2025
Virus Research Center, Clinical Research Division, Sendai Medical Center, Sendai 983-8520, Japan.
To better understand the phylogenomics of the hemagglutinin-neuraminidase () gene and HN protein in human parainfluenza virus type 4 (HPIV4), we performed phylogenomic analyses using various bioinformatics methods. The main bioinformatics analyses included a time-scaled phylogeny, genetic distance assessments, and three-dimensional (3D) structure mapping of the HN protein with conformational epitope and selective pressure analyses. The time-scaled phylogenetic tree indicated that the most recent common ancestor of the gene emerged approximately 100 years ago.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.